Hefu China (603122) Abnormal Stock Trading Risk Alert Analysis

Hefu China (603122) has recently experienced significant abnormal trading. According to reports [3], the company’s stock recorded 11 limit-up boards within 12 trading days, leading to sharp short-term fluctuations in the stock price.

In response to this abnormal trading, Hefu China has issued multiple risk alert announcements [1][2]. The announcements point out that the recent sharp increase in the company’s stock price may not match its fundamentals, and there is an obvious “pass the parcel” effect [3]. The company reminds investors to pay attention to investment risks and make rational decisions.

Currently, Hefu China’s main business is medical device distribution, and there are no major positive news or announcements of significant performance growth to support the abnormal rise in stock price. This stock price fluctuation is more likely due to short-term market speculative behavior rather than an increase in the company’s intrinsic value.

Investors should fully pay attention to the risk alert announcements issued by the company and avoid blind follow-up trading. Abnormal fluctuations in stock prices are often accompanied by high investment risks, so investors need to carefully evaluate their own risk tolerance.